title: Continuation of high-dose vancomycin despite nephrotoxicity.
authors.forename: Christine B
authors.initials: CB
authors.lastname: Teng
authors.forename: Katayoun
authors.initials: K
authors.lastname: Rezai
authors.forename: Gail S
authors.initials: GS
authors.lastname: Itokazu
authors.forename: Renee C
authors.initials: RC
authors.lastname: Xamplas
authors.forename: Robert C
authors.initials: RC
authors.lastname: Glowacki
authors.forename: Keith A
authors.initials: KA
authors.lastname: Rodvold
authors.forename: Robert A
authors.initials: RA
authors.lastname: Weinstein
authors.forename: David N
authors.initials: DN
authors.lastname: Schwartz
mesh_terms: D000900:Anti-Bacterial Agents; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000453:epidemiology*; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D014640:Vancomycin
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin